Web Analytics Made Easy - StatCounter

Feracrylum Gel Tenders

Get complete information related to latest Feracrylum Gel Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Feracrylum Gel Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Feracrylum Gel Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

Central Government/Public Sector

CTN :45737247 Due date: 23 Jul, 202623 Jul, 2026 NA
Tender For supply of sacubitril 24 mg and valsartan 26 mg oral tablet [ warranty period: 30 months after the date of delivery ] ]

CTN :45329333 Due date: 04 Jul, 202604 Jul, 2026 NA
Tender For corrigendum : e-bid for the finalization of rate contract for the procurement of allopathic drugs for the year 2026-28 - surfactant intratracheal suspension, each 4ml pack, inj. anti d 150mcg/vial,, inj. cyclophosphamide 500mg/vial,, tab. chlorpheniramine maleate 4mg, cap cyclosporin 50mg, cap. cyclosporin 100mg, budesonide respules 0.5mg/ml, 2ml respules, inj. iopromide injection 77% w/v, 370 mg i/ml, per 100ml bottle, inj. anti rabbies vaccine, 1ml vial, inj. hepatitis-b 10mcg, 0.5 ml, per vial/ampoule, inj. surfactant intratrachial suspension, 5ml, per vial, inj. tocilizumab 80mg, per vial, inj. tocilizumab injection 400mg, per vial, tab. bupropion extended release 150 mg, tab. naltrexone 50mg, permethrin cream 1% w/w, 30gm tube, inj. rh-erythropoietin 10000 iu, liquid chlorpheniramine maleate (pediatric only) 2 mg/5ml, 30 ml bottle, inj. diltiazem 5mg/ml, 5 ml single dose vial, tab. misoprostol 100 mcg, tab. pyridoxine 10 mg, inj. magnesium sulphate ip 50% w/v, 10 ml vial/amp, inj. theophylline and etofylline 50.6mg + 169.4mg 2ml amp., tab. eplerenon 25mg, recombinant coagulation factor vii a 2mg, 2ml vial, inj. emicizumab 105mg/0.7ml, per vial, inj. emicizumab 150mg/ml, per vial, inj. emicizumab 30mg/ml, per vial, inj. emicizumab 60mg/0.4ml, per vial, tab. zolpidem tartrate 10mg, inj. cefoperazone 250mg + salbactum 125mg, per vial, tablet levodops 100 m + carbidopa 10mg, ethyl alcohol (de-natured) solution 70% , 1 litre pack, inj. vinblastine 1mg/ml, per 10ml vial, injection dacarbazine 500mg, inj. amino acid 10% w/v,100ml bottle, inj. fluconazole 2mg/ml, per 100ml bottle, inj. vitamin b-complex nfi , vial, tab. zidovudine 100mg, tab. zidovudine 300mg, framycetin, dexamethason & clotrimazole cream 10 gm, inj. tirzepatide 2.5/0.5ml solution for inj vial /md pfs, inj. tirzepatide 5/0.5ml solution for inj vial /md pfs, inj. tirzepatide 7.5/0.5ml solution for inj vial /md pfs, inj. tirzepatide 10/0.5ml solution for inj vial /md pfs, inj. tirzepatide 12.5/0.5ml solution for inj vial /md pfs, inj. tirzepatide 15/0.5ml solution for inj vial /md pfs, inj. trastuzumab-deruxtecan concentrate solution for infusion 100mg/vial, lignocaine hydrochloride and dextrose 7.5 % 2 ml injection, tab. levocetirizine 10mg md, levodopa+ carbidopa 100mg+25g, 1x10 tab strip, iron dextran complex 50mg/ml, 2ml amp, verapamil 5mg/2ml,2ml amp, formaldehyde solution not less than 34.0% w/v, 500 ml bottle, ethinyl estradiol 0.05mg, anti-d immunoglobulin 1500 iu, vial, neomycin sulphate 3.5mg + polymyxin-b 10000 iu + hydrochortisone 10 mg/per ml, 5ml pack or neomycin sulphate 3400units+ polymyxin-b 10000 iu + hydrochortisone 10 mg/ per ml, 5ml pack, misoprostol 600 mcg 1 tab pack, salbutamol 5mg/ml,15 ml pack, levosalbutamol inhalation mdi dpi 50mcg dose 120ml pack (inhaler/rotacaps), budesonide inhalation mdi dpi 100mcg dose 200mdi pack, budesonide 100 mcg+ formoterol 6 mcg inhalation 120 metered doses, budesonide 160 mcg+ formoterol 4.5 mg inhalation powder, 60 metered doses, hydroxyethyl starch in isotonic sodium chloride iv infusion 6% 100ml bottle, rifampicin 150mg, 1x10 tab strip, clofazimine 50mg, 1x10 tab strip, ifosfamide 1gm/10ml vial, docetaxel 160mg/8ml vial,, iopromide injection 77% w/v, 370mg i/ml 50ml pack, iopromide 300mgi/ml 50ml pack, feracrylum gel 1%w/w 15gm tube, feracrylum 3%w/w guaze dressing (10cm x 10cm) pack, inj. pneumococcal polysacheride conjugate vaccine 14-valent 0.5ml vial/pfs, tab. misoprostol ip 25 mcg, 1 tab pack, cap. dutasteride ip 0.50 mg, tab. tamsulosin 0.4 mg, tablet sodium dichloroisocyanurate 75mg (available chlorine 45mg), meningcoccal vaccine 0.5 ml 10ug each of (meningococcal a, c, w, and y polysaccharides conjugated to approximately 55 g of tetanus toxoid protein carrier)inj., inj. mepolizumab 100mg, semaglutide solution injection (r-dna origin) 0.25mg, semaglutide solution injection (r-dna origin) 0.5mg, semaglutide solution injection (r-dna origin) 1mg, semaglutide solution injection (r-dna origin) 1.7m

CTN :45543542 Due date: 29 Jun, 202629 Jun, 2026 NA
Tender For corrigendum : sacubitril 97 mg+ valsartan 103 mg tablet

State Government

CTN :45376182 Due date: 15 Jul, 202615 Jul, 2026 NA
Tender For corrigendum : supply of albendazole oral suspension 200 mg/5 ml , betamethasone valerate cream 0.05 percent , oral liquid chloroquine phosphate 50 mg/5 ml , cholecalciferol granules (vitamin d3), 60,000 i.u. , ciprofloxacin ophthalmic solution 0.3 percent w/v , clotrimazole cream 1percent , syrup dextromethorphan 13.5 mg/ 5 ml , dicyclomine oral solution 10 mg/5ml , domperidone suspension 1 mg/ml , metronidazole benzoate oral suspension 100 mg/5 ml, 60 ml bottle , miconazole cream 2%, 15 gm tube , oral rehydration salts (o.r.s) .(w.h.o. formula), 20.5 gm sachet , paracetamol syrup 125 mg/5 ml- oral liquid , syrup/oral liquid salbutamol 2 mg/5 ml , silver sulphadiazine cream 1percent (500 gm) , timolol maleate eye drops 0.5percent, 5 ml vial , trimethoprim & sulphamethoxazole oral suspension, 50 ml bottle , calamine lotion , clotrimazole lotion 1percent , povidone iodine ointment 5 percent , silver sulphadiazine cream 1percent (20 gm) , azithromycin oral suspension 200 mg/5 ml , clobetasol propionate cream 0.05 percent , syrup levocetirizine 2.5 mg/5 ml , lactulose solution 3.335 gm/5 ml , magnesium sulphate powder , cyclopentolate eye drops 1percent w/v,5 ml vial , moxifloxacine eye drops 0.5percent w/v , prednisolone acetate eye drop 1percent w/v , brimonidine tartrate and timolol eye drops 0.15percent w/v + 0.5percent w/v (5 ml vial) , xylometazoline nasal drops 0.10 percent , moxifloxacin 0.5percent+ dexamethasone 0.1percent eye drops (preservative free) , natamycin (5percent) eye drops , travoprost eye drops 0.004percent , carboxy methyl cellulose 1percentliquigel , fluticasone 0.05 percent w/w cream , feracrylum gel 1 percent w/w, 15 gm tube , haemorrhoidal cream‐ beclomethasone dipropionate 0.025percent, phenyleherine hydrochloride 0.1percent , lignocaine hydrochloride 2.5percent

State Government

CTN :45271089 Due date: 14 Jul, 202614 Jul, 2026 NA
Tender For corrigendum : supply of t.e.no.gmscl/d-785 /rc/2026-27 - tablet allopurinol 100 mg, 2000, ip, 187500.00, each tablet contains: methotrexate ip 2.5 mg, 1138, box of 10x10 tablet in blister with aluminium back/ aluminium foil strip, tablet promethazine 25 mg, 1000, ip, 14000.00, each uncoated tablet contains glyceryl trinitrate ip 0.5 mg, 1328, box of 10x10 tablet/capsule in blister with aluminium back/ aluminium foil strip, tablet zln (zidovudine 300 mg + lamivudine 150 mg + navirapine 200 mg ), 1000, ip, 43800.00, each capsule contains: atazanavir ip 300 mg., 1338, each bottle contains 100 tablets, tablet nitazoxanide 500 mg, 1000, ip, 1253200.00, each controlled release 1000 mg tablet contains sodium valproate 666 mg ip + valproic acid 290 mg ip, 1417, box of 10x10 tablet/capsule in blister with aluminium back/ aluminium foil strip, tablet sodium bicarbonate 500 mg, 582000, _____, 10301900.00, each tablet contains colchicine ip 0.5 mg, 1469, box of 10x10 tablet/capsule in blister with aluminium back/ aluminium foil strip, capsule hydroxyurea 100 mg, 226000, ip, 398200.00, each tablet contains praziquantel ip 600 mg, 1500, each bottle contains 100 tablets, tablet prazosin hydrochloride ip 2.5 mg, 6000, ip, 359900.00, each sustained/ extended/ prolonged release tablet contains bupropion hydrochloride ip 150 mg, 1516, box of 10x10 tablet in blister with aluminium back/ aluminium foil strip, tablet rivastigmine 3 mg, 7000, ip, 98800.00, each tablets contains hydroxyzine hydrochloride ip 10mg, 1588, box of 10x10 tablet/capsule in blister with aluminium back/ aluminium foil strip, tablet valsartan 40mg, 9000, _, 811400.00, each tablet contains fenofibrate ip 145mg, 1632, box of 10x10 tablet in blister with aluminium back/ aluminium foil strip, tablet dimethyl fumarate 120mg, 46000, ip, 84500.00, each tablet contains dexamethasone ip 8 mg, 1639, box of 10x10 tablet in blister with aluminium back/ aluminium foil strip, tablet spirinolactone (25 mg ) +furosemide (20 mg ), 34000, ip, 7000.00, each tablet nitroglycerin controlled realease ip 2.6mg, 1674, box of 10x10 tablet in blister with aluminium back/ aluminium foil strip, tablet dapsone 300mg, 1000, ip, 345500.00, each tablet/capsule contains palbociclib 125mg, 2032, box of 25 x 2 ml ampoule, fentanyl citrate injection 50 mcg/ml, 172000, ip, 1134200.00

Central Government/Public Sector

CTN :45604799 Due date: 26 Jun, 202626 Jun, 2026 NA
Tender For supply of valsartan 40mg tablet ]

CTN :45085654 Due date: 10 Jun, 202610 Jun, 2026 NA
Tender For bid to ras bid to ras corrigendum : supply of echs gem 14 drugs 2025 26 c c - acarbose 50 mg tab , alfacalcidol vit d 3 0dot25mcg cap , allopurinol 100 mg tab , amoxycillin 875 mg plus clavalunic acid 125 mg tab , anti haemorhoidal ointment containing beclomethasone 0dot025 percent phenylephrine 0dot1 percent and lignocaine 2dot5 percent tube of 20 gm with applicator , tab apixaban 2dot5 mg , tab apixaban 5mg , aspirin 150 mg tab , asprin 75mg tab , azelastine hcl 140 mcg plus fluticasone propionate 50 mcg bp nasal spray , budesonide 0dot5mg respules , carvedilol 3dot125 mg tab , citicoline 500mg tab , clarithromycin 250mg tab , clotrimazole dusting powder bott of 100 gm candid foot powder , dabigatran etexilate 110mg capsule , tab dapagliflozin 10mg , divalproate 500 mg tab , doxophyllin 400 mg tab , carboxy methyl cellulose1 per eye drop bott of 10 ml , ciprofloxacin 0dot3percent eye drops of 3mg ml bott of 5 ml , ed dorzolamide 2percentw v , tab escitalopram 10 mg , etophylline 115 mg and theophylline 35 mg in slow release form tab , tab etoricoxib 90mg , febuxostat 40mg tab , fenofibrate 200 mg tab , fexofenadine 180 mg tab , flavoxate 200mg tab , fluticasone propionate 50mcg bp nasal spray , folic acid 5 mg tab , frusemide 20mg plus spironolactone 50mg tab , gabapentin 300 mg cap tab , gliclazide xr 60 mg tab , heamatinic tab cap containing a ferrous fumarate with 100 mg elemental iron b folic acid 500 mcg 1500 mcg , imatinib mesylate 400 mg , indapamide sr modified release prolonged release controlled release 1dot5 mg tab cap , tab ivabradine 5 mg , tab levetiracetam 500 mg , monteleukast 10mg plus levocetrizine 5mg tab , levo salbutamol 1dot25mg plus ipratropium 500mcg respule in 2dot5ml respule , lignocaine hcl jelly 2percent tube of 30 gm with sterile tube and short nozzle suitable for intra urethral use should be packed within a sterile blister pack , linezolid 600 mg tab , tab metformin 500 mg plus vildagliptin 50 mg , metoprolol extended release 50mg tab , mifepristone 200 mg tab , minoxidil 5percent lotion bott of 60ml , mometasone 0dot1per tube of 10gm , monteleukast 5 mg tab , mupirocin 2per oint tube of 5 gm , nicorandil 10 mg tab , nortriptyline 25mg tab , oxcarbazepine 300 mg tab , prazosin 2dot5 mg sustained release slow release tab , prednisolone 20mg tab , cap probiotic multibacillary 4 or more organisimis , tab sacubitril 24 mg plus valsartan 26mg , tab sodium bicarbonate 500mg , sodium valproate 200mg tab , sulphasalazine 500mg tab , amoxycillin 200 mg 5ml plus clavulanic acid 28dot5 mg 5ml syp in 30 ml bott , syp azithromycin 200mg per 5ml bottle of 15 ml , telmisartan 40 mg plus hydrochlorothiazide 12dot5 mg tab , thyroxine sodium 0dot1mg tab , thyroxine sodium 0dot025 mg tab , tab thyroxine 50 mcg , tofacitinib 5mg tablet , torsemide 10 mg tab , tranexamic acid 500 mg tab , urea cream urea 10 to 12 per lactic acid 5 to 10 perin pack of 50gm , vitamin e 200 mg cap //bid details 2 / 56

Central Government/Public Sector

CTN :45422802 Due date: 30 Jun, 202630 Jun, 2026 NA
Tender For corrigendum : supply of sacubitril 97 mg and valsartan 103 mg oral tablet [ warranty period: 30 months after the date of delivery ] ]

Central Government/Public Sector

CTN :45422709 Due date: 29 Jun, 202629 Jun, 2026 NA
Tender For corrigendum : sacubitril 49 mg and valsartan 51 mg oral tablet[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] [ rate of supply 2347 units per month , commencement time allowed -1 day ]

Central Government/Public Sector

CTN :45415921 Due date: 30 Jun, 202630 Jun, 2026 NA
Tender For e-tender for procurement of drug items under table-a, for two years from the date of aoc. - amoxicillin trihydrate dispersible tabs. i.p 125mg, amoxycillin 250 mg + cloxacillin 250mg capsule., atropine sulphate inj. i.p. 0.6 mg/ml-1ml amp., azacitidine inj 100 mg /vial, azathioprine 50 mg tab., benzyl benzoate application i.p 25% w/w-500 ml bot., bimatoprost eye drop 0.03%, bupivacaine 0.5% inj - 20ml vial, cabergoline tab 0.5mg, caffeine citrate 1 ml inj per vial/amp, carmustine inj. 100mg/vial, cefotaxime sodium inj. i.p. 125 mg.vial., ceftazidime inj. 1gm./vial, cetuximab inj. 100mg( 5mg/ml) / - 20ml vial, cetuximab inj. 500 mg (5mg/ml)/100ml vial, cilostazol tab ip 50 mg, clopidogrel 75mg tab., daclatasvir 60 mg tab., decitabine inj 50 mg, deferasirox 250mg dispersable tab., desflurence inhalation agent 240 ml, dexamethasone 4 mg tab., dexamethasone tab. i.p. 0.5 mg, diclofenac sod. 50 mg tab., diclofenac sodium injection i.p. 25mg/ml- 3ml amps, digoxin tablet i.p. 0.25 mg, dorzolamide hydrochloride 2.0% eye drop in 5ml, fexofenadine tab 120 mg, fibrin sealent with fast & slow setting of thrombin 1ml, fludarabine inj. - 50mg / 5ml, flurourocil inj. i.p. 250mg. in 5ml. amp., fluticasone nasal spray ip 50 mcg (in maximum of 120 mdi pack), furosemide inj. i.p 20mg/2ml. ampoule, halazone tablet for solution u.s.p. 4mg, human hepatitis b immunoglobulin inj. 200 iu volume in 0.5 ml or 1 ml vial/pfs, ibrutinib 140 mg cap., infliximab inj. 100mg/vial, isosorbide-5-mononitrate 20 mg, isosorbide-dinitrate tab i.p. 5mg., ivermectin 6mg tab., leuprolide depot inj. 22.5 mg/vial, levetiracetam inj. 100 mg /ml in 5ml amps, levofloxacin 500 mg tab., levosalbutamol 1.25 mg + ipratropium bromide 500mcg respules, levosalbutamol oral suspension 1mg/5ml, linezolid infusion 600 mg / 300ml, linezolid syrup 100mg / 5ml, melphalan hcl inj. 50 mg (powder), methotrexate tab 15 mg, naproxen 250mg tab., neostigmine methylsulphate inj.i.p. 0.5mg/ ml - 1ml ampoule, nicorandil tabs 5mg, ondansetron inj. 2mg/ ml in 2ml amp., penicillamine 250 mg. cap., plerixafor inj 24mg/1.2ml per vial, polymixin b sulfate inj. 5,00,000 units/vial, pomalidomide 2mg tab / cap, prednisolone tab.20mg., pyrazinamide tab. i.p. 500mg, pyridostigmine tab 30 mg, risperidone tab. 2 mg, sacubitril + valsartan tab. 50mg, sodium chloride inj 0.45% in polypropelene bottle in ffs technology, sodium fusidate cream / ointment 2%, solifenacin 5mg tab., succinylated polygelline, sulfasalazine tab 500 mg, teicoplanin inj. 200 mg /vial, tetanus toxoid inj. (absorbed) 0.5ml amp. single dose, thiamine 100 mg. inj. per 2ml ampule, tinidazole tab ip 500 mg, tropicamide 0.8% with phenylephrine hydrochloride 5% eye drop, valethamate bromide inj 8 mg/ml in 1ml amp., vecuronium bromide inj. 2mg /ml 2ml vial, important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender.2. tendered quantity is just a tentative quantity and should not be treated as final. it may increase or decrease, as per need of the state. keeping this in mind, the supplier is not allowed to seek termination of the rate contract after finishing supply of tendered quantity.3. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period.4. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi(b) in case of sole manufacturer/importer (i.e. proprietary in nature).5. if the item(s) under sole manufacturer / importer is (are) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item(s) proprietary in nature, otherwise their item(s) will be blocked in the smis.6. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f
 Loading, Please wait...

Connect us via What's Up